Moleculin Biotech Inc (MBRX) Receives Average Recommendation of "Strong Buy" from Brokerages

Moleculin Biotech Inc (MBRX) Receives Average Recommendation of "Strong Buy" from Brokerages


Shares of Moleculin Biotech Inc have received a consensus broker rating score of 1.00 from the one analysts that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.



from Biotech News
Share:

Allianz Asset Management GmbH Acquires Shares of 22,451 Esperion Therapeutics Inc

Allianz Asset Management GmbH Acquires Shares of 22,451 Esperion Therapeutics Inc


Allianz Asset Management GmbH acquired a new stake in shares of Esperion Therapeutics Inc during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 22,451 shares of the biopharmaceutical company's stock, valued at approximately $1,624,000.



from Biotech News
Share:

Missouri appeals court tosses $55 million J&J talc-powder verdict

Missouri appeals court tosses $55 million J&J talc-powder verdict


A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a lawsuit by a woman who claimed she developed ovarian cancer after using talc-based products, including J&J's baby powder, citing a U.S. Supreme court ruling on where such cases can be brought. FILE PHOTO: A bottle of Johnson and Johnson Baby Powder is seen in a photo illustration taken in New York, February 24, 2016.



from Biotech News
Share:

Six White & Case IP Partners Join Fenwick in New York

Six White & Case IP Partners Join Fenwick in New York


Six intellectual property litigation partners from White & Case in New York are joining Fenwick & West, marking the first addition of litigators to the Silicon Valley firm's Manhattan office since it launched in 2016. Litigators Jeffrey Oelke, Kevin McGann, James Trainor and Adam Gahtan joined the firm Tuesday, while Robert Counihan and Ryan Johnson plan to join Fenwick soon this summer.



from Biotech News
Share:

Apotex Faces Uncertainty After Founder's Mysterious Death

Apotex Faces Uncertainty After Founder's Mysterious Death


Barry Sherman, who died earlier this month under suspicious circumstances, had set the tone for generic drugmaker's aggressive litigation approach Late Apotex founder and chairman Barry Sherman paid close attention to the generic drugmaker's multiple lawsuits because he viewed them as an essential weapon against larger rivals, say lawyers familiar with his strategy. TORONTO-The path forward for Apotex Inc. is uncertain following the sudden death of founder and chairman Barry Sherman, who was the architect of the generic drugmaker's litigation-heavy strategy.



from Biotech News
Share:

's Daily Biotech Pulse: Gemphire On Fire,...

's Daily Biotech Pulse: Gemphire On Fire,...


Gemphire Therapeutics Inc said its gemcabene evaluated in a Phase 2b study dubbed INDIGO-1 for treating sever hypertriglyceridemia demonstrated statistically significant lowering of triglycerides. Secondary endpoints of statistically significant reductions in serum LDL cholesterol, non-HDL cholesterol, VLDL cholesterol, apoB, apoE, apoCIII, and SAA were also met.



from Biotech News
Share:

Sinovac Biotech (SVA) Downgraded by ValuEngine

Sinovac Biotech (SVA) Downgraded by ValuEngine


Separately, BidaskClub raised shares of Sinovac Biotech from a hold rating to a buy rating in a research note on Tuesday, March 20th. NASDAQ:SVA opened at $7.46 on Tuesday.



from Biotech News
Share:

Novartis to spin off Alcon, will buy back US$5 billion in shares

Novartis to spin off Alcon, will buy back US$5 billion in shares


Novartis unveiled its long-expected plan to spin off all of its Alcon eye care devices business and launch a share buyback of up to US$5 billion as the company sharpens its focus on prescription drugs, it said on Friday. FILE PHOTO: Swiss drugmaker Novartis' logo is seen at the company's plant in the northern Swiss town of Stein, Switzerland October 23, 2017.



from Biotech News
Share:

Romaine lettuce E. coli outbreak is over as new evidence points to tainted water

Romaine lettuce E. coli outbreak is over as new evidence points to tainted water


Romaine lettuce is displayed at a grocery store on May 2, 2018 in San Anselmo, California. One person in California has died from E. coli linked to romaine lettuce.



from Biotech News
Share:

Only 23% of U.S. adults are getting enough exercise, CDC report says

Only 23% of U.S. adults are getting enough exercise, CDC report says


A report from the CDC's National Center for Health Statistics found 23 percent of U.S. adults are meeting federal guidelines for time spent exercising. Only 23% of U.S. adults are getting enough exercise, CDC report says A report from the CDC's National Center for Health Statistics found 23 percent of U.S. adults are meeting federal guidelines for time spent exercising.



from Biotech News
Share:

Finanzen: Ehrenamtspauschale : Ehrenamtspauschale

Wer ehrenamtlich tätig ist, darf sich bis zu 720 Euro im Jahr steuer- und sozialversicherungsfrei dazuverdienen. Vereine können so das Engagement etwas belohnen.

from Finanztip Feed
Supported by Video Collection
Share:

Der Brexit – eine Gefahr für die Arzneimittelversorgung

Der Brexit – eine Gefahr für die Arzneimittelversorgung


Der Austritt Großbritanniens aus der Europäischen Union (EU) zum 29. März 2019 gefährdet die Sicherheit der Arzneimittelversorgung auf beiden Seiten. Die Politik ist nun gefordert, geeignete Maßnahmen zu ergreifen, um eine qualitativ hochwertige Versorgung zu gewährleisten. Aber auch die Industrie i...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

BIO Applauds SEC for Providing Regulatory Relief to Emerging Biotech Innovators

BIO Applauds SEC for Providing Regulatory Relief to Emerging Biotech Innovators


Jun 28, 2018--Biotechnology Innovation Organization President and CEO Jim Greenwood released the following statement regarding today's vote by the Securities and Exchange Commission : "I applaud the SEC for providing much-needed regulatory relief to small public companies. The broadened definition of 'smaller reporting company' will allow emerging biotech companies to spend more of their limited capital on lifesaving research, rather than unnecessary compliance costs.



from Biotech News
Share:

Finanzen: Kindergeld : Ratgeber Kindergeld

Kindergeld ist eine wichtige und zuverlässige Geldquelle für Eltern. Wie viel und wie lange Sie Kindergeld bekommen und worauf Sie achten müssen, erfahren Sie hier.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Nachhaltige Geldanlagen : Nachhaltige Geldanlagen

Nachhaltige Geldanlagen liegen im Trend. In ethisch ausgerichtete Indexfonds (ETFs) können Anleger günstig und guten Gewissens investieren.

from Finanztip Feed
Supported by Video Collection
Share:

Amgen: Don't Sleep on This Biotech Giant

Amgen: Don't Sleep on This Biotech Giant


When dealing with a highly volatile sector like biotechnology, it can pay to invest in the big guns. Amgen is an American multinational biopharmaceutical company headquartered in California.



from Biotech News
Share:

Finanzen: Steuervorteile für Eltern : Kindergeld und Freibeträge

Für Eltern gibt es eine Reihe an steuerlichen Vergünstigungen: Kindergeld, Kinderfreibetrag, Ausbildungsfreibetrag und weitere.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Freibeträge und Pauschbeträge : Steuerfreibetrag

Pauschbeträge und Freibeträge kommen für viele Steuerzahler infrage. Belege sind hierfür nicht nötig.

from Finanztip Feed
Supported by Video Collection
Share:

Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor

Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor


TOKYO: A group of Takeda Pharmaceutical Co Ltd shareholders, who are trying to build support to block the US$62 billion acquisition of London-listed Shire Plc , failed to get a proposal passed at the drugmaker's annual general meeting on Thursday. The proposal - to require advance shareholder approval for large acquisitions - received about 10 percent of votes in favor, the company confirmed to Reuters, casting doubt on the group's ability to gather enough support to scupper the Shire deal.



from Biotech News
Share:

CervicalCheck pays almost a 7m a year to three screening labs

CervicalCheck pays almost a 7m a year to three screening labs


CervicalCheck is paying out nearly a 7m a year to the three labs contracted to carry out screening, new documents reveal. CervicalCheck is paying out nearly a 7m a year to the three labs contracted to carry out screening, new documents reveal.



from Biotech News
Share:

UPDATE 2-Array BioPharma gets FDA nod for melanoma combo treatment

UPDATE 2-Array BioPharma gets FDA nod for melanoma combo treatment


The U.S. Food and Drug Administration said on Wednesday it approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer. A view shows the U.S. Food and Drug Administration headquarters in Silver Spring, Maryland August 14, 2012.



from Biotech News
Share:

Scientist awarded $2 million grant from the NIH to study the body's immune memory response

Scientist awarded $2 million grant from the NIH to study the body's immune memory response


IMAGE: The National Institute of Allergy and Infectious Diseases , part of the National Institutes of Health, has awarded a $2 million, five-year grant to Ken Oestreich, an assistant professor at... view The National Institute of Allergy and Infectious Diseases , part of the National Institutes of Health, has awarded a $2 million, five-year grant to Ken Oestreich, an assistant professor at the Virginia Tech Carilion Research Institute, to study immunological memory. The human immune system can "remember" invading pathogens, such as viruses, and can recognize intruders from previous infections and respond more quickly and robustly.



from Biotech News
Share:

Insider Selling: Vertex Pharmaceuticals Incorporated (VRTX) COO Sells 4,250 Shares of Stock

Insider Selling: Vertex Pharmaceuticals Incorporated (VRTX) COO Sells 4,250 Shares of Stock


Vertex Pharmaceuticals Incorporated COO Ian F. Smith sold 4,250 shares of Vertex Pharmaceuticals stock in a transaction dated Friday, June 22nd. The shares were sold at an average price of $160.00, for a total value of $680,000.00.



from Biotech News
Share:

Congress approves $400 million for Alzheimer's research

Congress approves $400 million for Alzheimer's research


Doctors at the National Institutes of Health say the additional funds could unlock new treatment options and could one day lead to prevention. "This has a tremendous impact.



from Biotech News
Share:

BioTechne snaps up Exosome Diagnostics in $250M deal

BioTechne snaps up Exosome Diagnostics in $250M deal


Minneapolis-based biotech supplier Bio-Techne Corp. has agreed to pay $250 million, and maybe more, to acquire a promising Boston-area firm that makes precision-medicine technology used to detect cancer without a tissue biopsy. Bio-Techne plans to acquire privately held Exosome Diagnostics, Inc. by early August, using cash on hand and a revolving line of credit.



from Biotech News
Share:

Illumina's Pullback Looks Like a Buying Opportunity for Further Gain

Illumina's Pullback Looks Like a Buying Opportunity for Further Gain


We looked at the charts and indicators at the end of May and I wrote that "ILMN is dipping slightly today and might see a retracement to around $250 or so but with no signs of significant distribution ILMN could well outperform on a relative and absolute basis over the next several months." ILMN stopped short of our $250 buy level and then rallied to new highs.



from Biotech News
Share:

New Haven Biotech Inks $150 Million Cash Now - Deal

New Haven Biotech Inks $150 Million Cash Now - Deal


NEW HAVEN: Biohaven Pharmaceutical Holding Company Ltd. [NYSE: BHVN] based in the city's downtown has just shown the wisdom of its licensing and developing programs. Royalty Pharma a New York based bioscience investment firm has agreed to purchase a tiered, sales-based participation rights on future global net sales of products containing rimegepant, the company's migraine treatment in development.



from Biotech News
Share:

Merck ups focus on materials biz, where Korea is big market

Merck ups focus on materials biz, where Korea is big market


German chemical and life sciences giant Merck KGaA has restructured its performance materials business with aims to strengthen its growth this year - a move that hints at Merck's renewed attention to its key customers in the space including South Korean display makers Samsung and LG. Merck recently initiated a major restructuring of its performance materials business division.



from Biotech News
Share:

Analysts' Recent Ratings Updates for Arrowhead Pharmaceuticals

Analysts' Recent Ratings Updates for Arrowhead Pharmaceuticals


They now have a $13.00 price target on the stock. They wrote, ": We are reiterating our Overweight rating and $13 PT for the completed enrollment of the Phase 1 trial of ARO-AAT for the treatment of Alpha-1 liver disease.



from Biotech News
Share:

Finanzen: Auszahlung der Lebensversicherung : Auszahlplan fürs Alter

Die Auszahlung der Lebensversicherung steht an. Mit Auszahlplan (Entnahmeplan) aus ETF-Vermögen oder Sofortrente sichern Sie sich Zusatzrente.

from Finanztip Feed
Supported by Video Collection
Share:

Amalgamated Bank Increases Position in AmerisourceBergen Corp.

Amalgamated Bank Increases Position in AmerisourceBergen Corp.


Amalgamated Bank boosted its holdings in shares of AmerisourceBergen Corp. by 10.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,317 shares of the company's stock after acquiring an additional 2,294 shares during the period.



from Biotech News
Share:

Taro Pharmaceutical Industries Ltd. (TARO) Shares Bought by A.R.T. Advisors LLC

Taro Pharmaceutical Industries Ltd. (TARO) Shares Bought by A.R.T. Advisors LLC


A.R.T. Advisors LLC lifted its holdings in shares of Taro Pharmaceutical Industries Ltd. by 48.7% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,690 shares of the company's stock after buying an additional 3,500 shares during the period.



from Biotech News
Share:

Sirius XM Holdings (SIRI) Hit By Barclays Downgrade; Ecor1 Capital...

Sirius XM Holdings (SIRI) Hit By Barclays Downgrade; Ecor1 Capital...


New York-listed Sirius XM Holdings Inc , was downgraded by stock research analysts at Barclays. Barclays downgraded its rating on the $31.62B market cap company to a Sell.



from Biotech News
Share:

Alnylam Pharmaceuticals, Inc. (ALNY) Position Decreased by Amundi Pioneer Asset Management Inc.

Alnylam Pharmaceuticals, Inc. (ALNY) Position Decreased by Amundi Pioneer Asset Management Inc.


Amundi Pioneer Asset Management Inc. cut its holdings in shares of Alnylam Pharmaceuticals, Inc. by 20.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 102,902 shares of the biopharmaceutical company's stock after selling 27,000 shares during the quarter.



from Biotech News
Share:

JMU Lands $1 Million Grant To Advance Inclusiveness

JMU Lands $1 Million Grant To Advance Inclusiveness


James Madison University is the recipient of a $1 million grant from The Howard Hughes Medical Institute to advance inclusiveness among first generation and community college transfer students in the biology department. The Inclusive Excellence grant will take effect starting in the fall over a five-year period.



from Biotech News
Share:

A.R.T. Advisors LLC Buys Shares of 59,510 Vanda Pharmaceuticals Inc.

A.R.T. Advisors LLC Buys Shares of 59,510 Vanda Pharmaceuticals Inc.


A.R.T. Advisors LLC bought a new stake in shares of Vanda Pharmaceuticals Inc. in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 59,510 shares of the biopharmaceutical company's stock, valued at approximately $1,002,000.



from Biotech News
Share:

Brokerages Set Johnson & Johnson (JNJ) Target Price at $141.44

Brokerages Set Johnson & Johnson (JNJ) Target Price at $141.44


Shares of Johnson & Johnson have been assigned an average recommendation of "Hold" from the twenty-five analysts that are covering the company, MarketBeat Ratings reports. Six investment analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and ten have issued a buy recommendation on the company.



from Biotech News
Share:

Leadership Team Announced for Keurig Dr Pepper

Leadership Team Announced for Keurig Dr Pepper


Our new leadership team represents the very best talent across both great companies," stated Bob Gamgort, future CEO of Keurig Dr Pepper. " With proven track records of delivering strong results, I am pleased to have these experienced executives join me in creating a new challenger in the beverage industry.



from Biotech News
Share:

80,761 Shares in Eli Lilly And Co (LLY) Acquired by Mount Yale Investment Advisors LLC

80,761 Shares in Eli Lilly And Co (LLY) Acquired by Mount Yale Investment Advisors LLC


Mount Yale Investment Advisors LLC bought a new stake in Eli Lilly And Co during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 80,761 shares of the company's stock, valued at approximately $6,248,000.



from Biotech News
Share:

Repatha study shows cholesterol reduction for Type 2 diabetes patients

Repatha study shows cholesterol reduction for Type 2 diabetes patients


Amgen announced the release of new data from a phase 3 study June 23 that showed its cholesterol drug Repatha reduced two key types of cholesterol by more than 50 percent in patients with Type 2 diabetes. Presented at the American Diabetes Association annual meeting, the study - dubbed Banting by the Thousand Oaks biotech giant - evaluated Repatha on a monthly dosing schedule.



from Biotech News
Share:

Unkontrollierter Brexit hätte für Chemie- und Pharmabranche gravierende Folgen

Unkontrollierter Brexit hätte für Chemie- und Pharmabranche gravierende Folgen


Der Verband der Chemischen Industrie (VCI) betrachtet mit zunehmender Sorge, dass auch zwei Jahre nach dem Brexit-Referendum im Vereinigten Königreich noch immer keine Einigung bei wichtigen Fragen in Sicht ist. VCI-Haupt­geschäfts­führer Utz Tillmann warnt: „Zwar gibt es eine politische Zusage der ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Non-invasive malaria test wins Africa engineering prize

Non-invasive malaria test wins Africa engineering prize


In this photo taken Monday, June 18, 2018, Ugandan Brian Gitta, left, and team members Moris Atwine, center, and Shafik Sekito, right, show the non-invasive malaria test that Gitta invented in Kampala, Uganda. Languishing with fever and frustrated by delays in diagnosing his illness, Gitta came up with a bright idea: a malaria test that would not need blood samples or specialized laboratory technicians.



from Biotech News
Share:

Ship with reported norovirus outbreak stops in Alaska

Ship with reported norovirus outbreak stops in Alaska


The U.S. Centers for Disease Control and Prevention report an outbreak of norovirus on a cruise ship in Alaska. KTOO public media reports 73 people have reported getting sick on the Holland America cruise ship Zaandam.



from Biotech News
Share:

Filing reveals former Bdsi Ceo's 2017 compensation

Filing reveals former Bdsi Ceo's 2017 compensation


Mark Sirgo , former CEO of BioDelivery Sciences International Inc ., received a little more than $2.4 million in total compensation during the company's 2017 fiscal year, according to a filing with the Securities and Exchange Commission. That's up from the $1.8 million he earned the year prior.



from Biotech News
Share:

Teen pregnancy rates declining, but don't take the good news for granted

Teen pregnancy rates declining, but don't take the good news for granted


May, recognized as National Teen Pregnancy Prevention Month, may be over, but the steamy days, flowering trees and hormonal flourishing continue to remind us that fecundity is the theme of the season.



from Biotech News
Share:

DZ Bank Reiterates Hold Rating for Eli Lilly And Co

DZ Bank Reiterates Hold Rating for Eli Lilly And Co


's stock had its "hold" rating reissued by equities researchers at DZ Bank in a research report issued on Friday. Several other research analysts also recently commented on the stock.



from Biotech News
Share:

Man Saved from Rip Current Thanks Heroic Rescuers

Man Saved from Rip Current Thanks Heroic Rescuers


San Diego lifeguards saved the man who was in an area restricted to swimmers. NBC 7's Steven Luke reports from La Jolla.



from Biotech News
Share:

Study Replicates Effectiveness of Blood Test for Autism

Study Replicates Effectiveness of Blood Test for Autism


A follow-up study confirms that a blood test can help to predict within an 88 percent accuracy whether a child has autism. The new research supports work performed a year ago that suggested the test has the potential to lower the age at which children are diagnosed, leading to earlier treatment.



from Biotech News
Share:

Fort Mill-based Lash Group to lay off 200 workers in Pittsburgh area

Fort Mill-based Lash Group to lay off 200 workers in Pittsburgh area


A Fort Mill-based subsidiary of drug wholesale company AmerisourceBergen plans to lay off 202 employees in the Pittsburgh area, according to a notice filed with the state.



from Biotech News
Share:

WVU researchers investigate link between sleep apnea treatment, diabetes management

WVU researchers investigate link between sleep apnea treatment, diabetes management


Courtesy photo During Robert Stansbury's study of how using a CPAP machine may improve diabetes self-management in diabetic sleep apnea patients, participants will wear pedometers to help measure their activity level.



from Biotech News
Share:

Celgene Corporation Announces Appointment of Jonathan Biller as Executive Vice President and General Counsel Following the Departure of Gerald F. Masoudi

Celgene Corporation Announces Appointment of Jonathan Biller as Executive Vice President and General Counsel Following the Departure of Gerald F. Masoudi


Jun 19, 2018--Celgene Corporation today announced the appointment of Jonathan Biller as Executive Vice President and General Counsel effective July 3, 2018. Mr. Biller will be responsible for global legal strategy and will serve on the company's Executive Committee.



from Biotech News
Share:

Finanzen: Zinsentwicklung und -prognose : Zinsentwicklung

Wer Geld anlegen oder einen Kredit aufnehmen möchte, sollte die Zinsentwicklung im Blick behalten. Denn die Zinsentwicklung ist wichtig für jede Finanzentscheidung.

from Finanztip Feed
Supported by Video Collection
Share:

GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

GSK takes billion-dollar drug fight with Gilead to top AIDS meeting


GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world's leading AIDS conference next month by showcasing detailed results from its new two-drug treatment. FILE PHOTO: Dolutegravir pills used in the treatment of HIV are seen at the Kenyan ministry of health offices in Nairobi, Kenya, June 27, 2017.



from Biotech News
Share:

Birmingham biotech firm's product scores positive results in UAB test

Birmingham biotech firm's product scores positive results in UAB test


A recent trial by researchers at the University of Alabama at Birmingham yielded positive results for a Birmingham-based biotechnology company's product. UAB researchers successfully used Circulogene Theranostics' molecular testing to identify multiple mutations in advanced ovarian cancer patients following chemotherapy and surgery.



from Biotech News
Share:

Finanzen: Brutto-Netto-Rechner : Brutto-Netto-Rechner

Wie viel bleibt vom Bruttogehalt übrig? Diese Frage beantwortet der Brutto-Netto-Rechner – zum Beispiel, wie sich eine Gehaltserhöhung auswirkt.

from Finanztip Feed
Supported by Video Collection
Share:

Roche übernimmt restliche Anteile an Partner Foundation Medicine

Roche übernimmt restliche Anteile an Partner Foundation Medicine


(dpa-AFX) Der Pharmakonzern Roche übernimmt seinen langjährigen Partner Foundation Medicine komplett. Die Schweizer erwerben die restlichen Anteile an dem in der Krebsforschung tätigen US-Unternehmens für 137 US-Dollar je Aktie und zahlen hierfür 2,4 Milliarden US-Dollar, wie der Pharmakonzern am Di...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Boehringer Ingelheim verkauft Produktionsstandort in Spanien

Boehringer Ingelheim verkauft Produktionsstandort in Spanien


(dpa) Der Pharmakonzern Boehringer Ingelheim plant den Verkauf eines Produktionsstandortes für Wirkstoffe im spanischen Malgrat. Die Veräußerung solle bis Ende dieses Jahres abgeschlossen sein, sagte eine Unternehmenssprecherin am Dienstag in Ingelheim. Zuvor hatte die «Frankfurter Allgemeine Zeitun...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Sanofi wirbt Finanzchef von Peugeot ab

Sanofi wirbt Finanzchef von Peugeot ab


(dpa) Der französische Pharmakonzern Sanofi holt seinen neuen Finanzchef vom Autobauer PSA Peugeot Citroen. Jean-Baptiste Chasseloup de Chatillon, bisher Finanzvorstand bei PSA, werde zum 1. September zu Sanofi wechseln, teilte der Pharmariese am Dienstag in Paris mit. Dort folgt er auf Jerome Conta...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Auszeichnungen für Gründer aus den Bereichen Life Sciences, Chemie und Energie

Auszeichnungen für Gründer aus den Bereichen Life Sciences, Chemie und Energie


image description
Die Rekord-Bilanz der Businessplanphase des Science4Life Venture Cup kann sich sehen lassen: In der diesjährigen Jubiläumsrunde wurde mit 82 eingereichten Businessplänen aus Deutschland, Österreich und der Schweiz ein Allzeithoch in der Geschichte von Deutschlands größtem branchengebundenen Business...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Seattle Genetics Sees Unusually Large Options Volume

Seattle Genetics Sees Unusually Large Options Volume


Seattle Genetics, Inc. was the recipient of unusually large options trading on Monday. Stock traders bought 1,202 put options on the company.



from Biotech News
Share:

New Hampshire confirms 1 case related to salmonella outbreak

New Hampshire confirms 1 case related to salmonella outbreak


New Hampshire health officials say one person in New Hampshire has been infected by salmonella in an outbreak linked to Honey Smacks cereal. The Kellogg Company last week voluntarily recalled some of its Honey Smacks cereal after salmonella infected 73 people in 31 states.



from Biotech News
Share:

Finanzen: Haushaltshilfe : Haushaltsnahe Beschäftigung

Einen Teil der Kosten für einen Minijobber im Privathaushalt können Sie sich über die Steuer zurückholen.

from Finanztip Feed
Supported by Video Collection
Share:

Roche SMA drug shines in study as costly new therapies advance

Roche SMA drug shines in study as costly new therapies advance


A drug being co-developed by Roche to treat spinal muscular atrophy helped improve development scores in babies with the genetic disease, a study released on Monday showed, as the race heats up for therapies destined to be among the drug industry's most expensive. PTC Therapeutics, which struck a licensing deal with Roche in 2011 for its SMA program, said more than 90 percent of babies with severe Type 1 SMA given the RG7916 drug achieved a greater than four-point increase in a test to measure their neuromuscular progress six months after treatment began.



from Biotech News
Share:

Markets Right Now: Stocks look to recover from early skid

Markets Right Now: Stocks look to recover from early skid


Stocks are mostly lower Monday, although they've pared some early losses as energy companies and smaller companies post gains. Household goods makers and health care companies are seeing the biggest losses, with Johnson & Johnson down 1.3 percent and Colgate-Palmolive off 2.2 percent.



from Biotech News
Share:

SPDR S&P Biotech (Xbi) Shares Bought by LPL Financial LLC

SPDR S&P Biotech (Xbi) Shares Bought by LPL Financial LLC


LPL Financial LLC lifted its position in SPDR S&P Biotech by 5.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 270,131 shares of the exchange traded fund's stock after buying an additional 14,044 shares during the quarter.



from Biotech News
Share:

ASX advances despite resource stocks falling on US-China tensions

ASX advances despite resource stocks falling on US-China tensions


The S&P/ASX 200 index rose 10.1 points, or 0.2 per cent, to 6104.1 as stocks on the benchmark index traded cautiously. The ASX rose on Monday on the strength of the banks who were able to shake off losses made by the miners.



from Biotech News
Share:

Evotec übernimmt 100 Sanofi-Mitarbeiter

Evotec übernimmt 100 Sanofi-Mitarbeiter


Evotec AG gab die Unterzeichnung einer verbindlichen Vereinbarung mit Sanofi bekannt, in deren Rahmen Evotec Sanofis Antiinfektiva-Einheit, sowie das damit verbundene Antiinfektiva-Forschungsportfolio in ihre Organisation integrieren wird. Die exklusiven Verhandlungen zwischen beiden Unternehmen und...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Meridian Bioscience, Inc. (VIVO) Position Lessened by New York State Common Retirement Fund

Meridian Bioscience, Inc. (VIVO) Position Lessened by New York State Common Retirement Fund


New York State Common Retirement Fund reduced its position in shares of Meridian Bioscience, Inc. by 46.6% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 565,334 shares of the company's stock after selling 493,653 shares during the period.



from Biotech News
Share:

Zacks: Cellect Biotech/S (Apop) Given Consensus Rating of "Strong Buy" by Analysts

Zacks: Cellect Biotech/S (Apop) Given Consensus Rating of "Strong Buy" by Analysts


CELLECT BIOTECH/S has been given an average broker rating score of 1.00 from the one brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy recommendation.



from Biotech News
Share:

$3.52 Earnings Per Share Expected for Amgen, Inc. (AMGN) This Quarter

$3.52 Earnings Per Share Expected for Amgen, Inc. (AMGN) This Quarter


Analysts expect Amgen, Inc. to report earnings of $3.52 per share for the current fiscal quarter, according to Zacks Investment Research . Seven analysts have provided estimates for Amgen's earnings, with the lowest EPS estimate coming in at $3.10 and the highest estimate coming in at $3.66.



from Biotech News
Share:

Highland Capital Management LP Buys Shares of 40,000 AstraZeneca plc

Highland Capital Management LP Buys Shares of 40,000 AstraZeneca plc


Highland Capital Management LP bought a new position in AstraZeneca plc during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 40,000 shares of the company's stock, valued at approximately $1,399,000.



from Biotech News
Share:

Kellogg's Honey Smacks cereal tied to salmonella, 73 sick, product recalled

Kellogg's Honey Smacks cereal tied to salmonella, 73 sick, product recalled


The Honey Smacks-linked salmonella outbreak has affected 73 people in 31 states so far, the Centers for Disease Control and Prevention said. The CDC is urging consumers to throw out or return any Kellogg's Honey Smacks cereal as it may be contaminated with salmonella.



from Biotech News
Share:

Pharmaceutical distributor to close Connecticut plant

Pharmaceutical distributor to close Connecticut plant


Pharmaceutical distribution giant McKesson is closing a Rocky Hill center at a cost of 105 jobs, according to a filing with the Connecticut Department of Labor. McKesson is based in San Francisco, with the company distributing a wide range of prescription drugs and other medical supplies, including opioids to alleviate pain.



from Biotech News
Share:

YouTube Backlinks: Wie man legitime Links vom Video Giant bekommt


YouTube Backlinks: Wie man legitime Links vom Video Giant bekommt

Wusstest du, dass über 300 Stunden Video jede Minute auf YouTube hochgeladen werden?
Das heißt, "Der Pate Teil II" über 90 Mal zu sehen. (Das ist eine Menge von Al Pacino und Robert De Niro ... puh.)
Es ist keine Überraschung, dass YouTube ein mächtiges Werkzeug für Verbraucher und Unternehmen ist. Mehr als 65% der Menschen sind visuelle Lerner, was videobasierten Websites wie YouTube zu Popularität und Erfolg verholfen hat.
Dieser Wert hat sich seitdem in Form von Markenexposure und Suchmaschinenoptimierung auf Unternehmen ausgeweitet. Tatsächlich ist C.
(Als Referenz wird Trust Flow von eins bis 100 gemessen. Also würde ich sagen, dass 99 wirklich gut ist.)
Einen Backlink von YouTube zu erhalten, ist wahnsinnig wertvoll.
Mein neues Youtube-Channel

from Мобильный Путешественник https://ift.tt/2MyLyMK
via Video Collection
Share:

Big Biotech Set for Earnings Blowout?

Big Biotech Set for Earnings Blowout?


Earlier this year, Oppenheimer's Hartaj Singh argued that earnings expectations were too high for big biotech companies heading into the first-quarter reporting season. However, as we approach the second-quarter, he thinks things may be looking up.



from Biotech News
Share:

First Light Asset Management LLC Has $14.90 Million Position in Immunomedics, Inc.

First Light Asset Management LLC Has $14.90 Million Position in Immunomedics, Inc.


First Light Asset Management LLC lifted its position in Immunomedics, Inc. by 8.0% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,019,920 shares of the biopharmaceutical company's stock after purchasing an additional 75,516 shares during the quarter.



from Biotech News
Share:

Finanzen: Handwerkerkosten : Handwerkerleistungen

Wenn Handwerker in Ihrer Wohnung arbeiten, kann das eine Steuererleichterung bis zu 1.200 Euro im Jahr bringen. Abzugsfähig sind die überwiesenen Arbeits- und Fahrtkosten.

from Finanztip Feed
Supported by Video Collection
Share:

Fewer US teens smoking, doing drugs ... and drinking milk

Fewer US teens smoking, doing drugs ... and drinking milk


This June 8, 2007 file photo shows a glass of milk on a table during a family breakfast in Montgomery, Ala. Nearly 20 years ago, about nearly half of high school students said they drank at least one glass of milk a day.



from Biotech News
Share:

Finanzen: Mercedes-Abgasskandal : Mercedes-Rückruf

Mercedes-Rückruf: Daimler muss im Diesel-Abgasskandal rund 240.000 Fahrzeuge in die Werkstatt holen. Welche Modelle betroffen sind und was Sie tun können.

from Finanztip Feed
Supported by Video Collection
Share:

Empathy, empowerment, engagement: How to talk about suicide with loved ones

Empathy, empowerment, engagement: How to talk about suicide with loved ones


The world is still reeling from the recent deaths of designer Kate Spade and chef and writer Anthony Bourdain. These tragedies have drawn the country's attention as rates of suicide continue to climb.



from Biotech News
Share:

First Wilshire Securities Management Inc. Has $5.16 Million Position in Trinity Biotech plc

First Wilshire Securities Management Inc. Has $5.16 Million Position in Trinity Biotech plc


First Wilshire Securities Management Inc. lowered its holdings in Trinity Biotech plc by 2.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,000,874 shares of the company's stock after selling 25,750 shares during the quarter.



from Biotech News
Share:

Finanzen: PKV Ratgeber : Private Krankenversicherung (PKV)

Die private Krankenversicherung lockt mit besseren Leistungen und günstigen Einstiegstarifen. Im Alter aber kann es teuer werden. Deshalb sollten Sie den Wechsel gut kalkulieren und niemals ohne Beratung angehen.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: GKV-Ratgeber : Gesetzliche Krankenversicherung (GKV)

Ein Wechsel der gesetzlichen Kasse ist unproblematisch. So recherchieren Sie die Kassen mit den besten Zusatzleistungen für Ihre Bedürfnisse.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Auslands-Sim-Karten : Sim-Karte mit Auslandstarif

Wer längere Zeit verreist, sollte sich eine ausländische Sim-Karte besorgen, um preiswert das Handy nutzen zu können. Es gibt Anbieter, die die Auslands-Sim-Karte noch vor Abreise nach Hause liefern.

from Finanztip Feed
Supported by Video Collection
Share:

Lilly's lupus treatment succeeds in mid-stage trial

Lilly's lupus treatment succeeds in mid-stage trial


Eli Lilly & Co said its drug to treat autoimmune disease lupus met the main goal of a mid-stage trial, positioning the drugmaker to begin a bigger study later this year. FILE PHOTO: The logo and ticker for Eli Lilly and Co.



from Biotech News
Share:

Finanzen: Flugänderung Pauschalreise : Flugänderung Pauschalreise

Wenn sich der Flug bei Ihrer Pauschalreise verschiebt, können Sie Geld zurückbekommen. Bei einer erheblichen und unzumutbaren Verschiebung können Sie die Reise sogar kostenlos stornieren.

from Finanztip Feed
Supported by Video Collection
Share:

She was sexually assaulted within months of coming out. She isn't alone.

She was sexually assaulted within months of coming out. She isn't alone.


People who identify as LGBTQ are at greater risk of sexual violence, according to the Centers for Disease Control and Prevention. Sarah McBride wasn't sure if she could do it.



from Biotech News
Share:

Finanzen: Freiwillig GKV versichert : Freiwillig gesetzlich krankenversichert

Niemand muss sich privat krankenversichern. Das gilt auch, wenn die Pflichtversicherung in der gesetzlichen Kasse endet. Wer sich freiwillig versichert, zahlt oft höhere Mindestbeiträge als Pflichtversicherte.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Billiger telefonieren ins Ausland : Billig telefonieren ins Ausland

Wer mit Freunden oder Familie im Ausland telefoniert, zahlt oft einen hohen Preis. Wir stellen günstige Alternativen vor.

from Finanztip Feed
Supported by Video Collection
Share:

All that food at work is making us unhealthy, study finds

All that food at work is making us unhealthy, study finds


A study conducted by the Centers for Disease Control and Prevention finds a lot of food available in the workplace isn't healthy. The study used data from a U.S. Department of Agriculture survey, focusing on purchases made by more than 5,000 employees from vending machines or cafeterias, as well as food available in the workplace for free.



from Biotech News
Share:

J&J verkauft LifeScan für gut 2 Milliarden US-Dollar

J&J verkauft LifeScan für gut 2 Milliarden US-Dollar


(dpa-AFX) Der US-Gesundheitskonzern Johnson & Johnson will seinen Ableger LifeScan verkaufen. Man habe ein entsprechendes Angebot der amerikanischen Private-Equity-Firma Platinum Equity in Höhe von 2,1 Milliarden US-Dollar angenommen, teilte J&J am Dienstag nach US-Handelsschluss mit. Lifescan ist e...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Wie viel verdient man eigentlich in einem Startup?

Wie viel verdient man eigentlich in einem Startup?


image description
Wie viel Geld können Beschäftigte in jungen Startups verdienen? Wie groß ist der Lohnunterschied im Vergleich zur klassischen Industrie? Antworten auf diese und weitere Fragen liefert die Startup-Studie 2018 von Gehalt.de in Kooperation mit Gründerszene Karriere. Untersucht wurden 1.600 Gehaltsangab...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Die Sieger des ACHEMA-Gründerpreises 2018 stehen fest

Die Sieger des ACHEMA-Gründerpreises 2018 stehen fest


Acht Finalisten hatten es in die Endrunde geschafft, drei durften im Rahmen der ACHEMA-Eröffnung ihre Pokale entgegennehmen: Plasmion, HeiDelTec und Watttron sind die Sieger des ACHEMA-Gründerpreises 2018 und erhalten ein Preisgeld von je 10.000 Euro. Plasmion überzeugte die Expertenjury mit seiner ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Daten-Roaming : Daten-Roaming

Wenn Sie im Ausland mit dem Handy surfen, „roamen“ Sie. Während Sie innerhalb der EU keine hohen Kosten fürchten müssen, kann Daten-Roaming außerhalb Europas schnell teuer werden.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Roaming (Handy im Ausland) : Roaming-Gebühren

Wenn Sie im Ausland zum Handy greifen, kann es teuer werden. In der EU verhindert die Roaming-Verordnung zusätzliche Kosten. Helfen können auch Auslandsoptionen oder ausländische Sim-Karten.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Befristeter Arbeitsvertrag : Befristeter Arbeitsvertrag

Jeder zwölfte Arbeitsvertrag ist befristet. Für Arbeitnehmer kann ein Zeitvertrag die Chance bieten, Berufserfahrung zu sammeln. Bestenfalls klappt der Wechsel zur Festanstellung. Junge Frauen sind durch befristete Verträge allerdings benachteiligt.

from Finanztip Feed
Supported by Video Collection
Share:

TG Therapeutics (TGTX), Solid Biosciences Inc (SLDB): This Biotech...

TG Therapeutics (TGTX), Solid Biosciences Inc (SLDB): This Biotech...


Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages. We only allow registered users to use ad blockers.



from Biotech News
Share:

Biotech, Nektar Therapeutics Can't Handle Mondays

Biotech, Nektar Therapeutics Can't Handle Mondays


Nektar Therapeutics went on a rollercoaster ride last week, and is down again today, following a downgrade, along with much of the rest of biotech. Two Mondays in a row of dipping into the red.



from Biotech News
Share:

Finanzen: Stromanbieter-Vergleich : Energieversorger

Verbraucher können frei wählen, wer ihnen Strom und Gas liefert. Wir erläutern, wie der Markt aussieht, welche Pflichten die Energieversorger haben und wer sie beaufsichtigt.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Prepaid-Tarife : Prepaid-Tarife

Prepaid-Tarife sind vor allem für Kinder und unbedarfte Nutzer sinnvoll. Gute Angebote gibt es von der Telekom und von Vodafone.

from Finanztip Feed
Supported by Video Collection
Share:

3 Deaths by Suicide in Tennessee Almost Daily

3 Deaths by Suicide in Tennessee Almost Daily


The Tennessee Suicide Prevention Network wishes to respond to the recent report through Centers for Disease Control and Prevention on "Trends in State Suicide Rates - United States, 1999-2016 and Circumstances Contributing to Suicide" . In any given day, three people in Tennessee die by suicide.



from Biotech News
Share:

Taiwan's biotech industry stands at a crossroadsi

Taiwan's biotech industry stands at a crossroadsi


The election of Taiwan's current president, Tsai Ing-wen, was widely expected to usher in a golden age for the island's biotech sector. An alumna of that sector, Tsai used to chair a prominent biotech start-up, TaiMed Biologics.



from Biotech News
Share:

Eli Lilly And Co (Lly) Position Reduced by British Columbia Investment Management Corp

Eli Lilly And Co (Lly) Position Reduced by British Columbia Investment Management Corp


BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp decreased its position in Eli Lilly And Co by 6.2% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 373,074 shares of the company's stock after selling 24,698 shares during the period.



from Biotech News
Share:

U.S. Suicide Rates Increased More Than 25% Since 1999, CDC Says

U.S. Suicide Rates Increased More Than 25% Since 1999, CDC Says


Suicide rates increased by 25% across the United States over nearly two decades ending in 2016, according to research published Thursday by the US Centers for Disease Control and Prevention. Twenty-five states experienced a rise in suicides by more than 30%, the government report finds.



from Biotech News
Share:

Gilead Sciences, Inc. (GILD) Stake Raised by HM Payson & Co.

Gilead Sciences, Inc. (GILD) Stake Raised by HM Payson & Co.


HM Payson & Co. increased its holdings in shares of Gilead Sciences, Inc. by 20.8% during the 1st quarter, HoldingsChannel.com reports.



from Biotech News
Share:

Analyzing Anika Therapeutics

Analyzing Anika Therapeutics


Anika Therapeutics and Lombard Medical Technologies are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations and valuation. This is a summary of recent recommendations and price targets for Anika Therapeutics and Lombard Medical Technologies, as reported by MarketBeat.com.



from Biotech News
Share:

Glenmede Trust Co. NA Raises Position in Pfizer Inc.

Glenmede Trust Co. NA Raises Position in Pfizer Inc.


Glenmede Trust Co. NA lifted its stake in Pfizer Inc. by 37.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission .



from Biotech News
Share:

Georgia impacted by pre-cut melon salmonella outbreak

Georgia impacted by pre-cut melon salmonella outbreak


According to the Centers for Disease Control and Prevention, the outbreak in eight states has been linked to pre-cut melon sold at Walmart, Costco, Jay C, Payless, Whole Foods, Sprouts, Trader Joe's, Walgreens and Kroger stores.



from Biotech News
Share:

More cases linked to Puyallup hospital Hepatitis outbreak

More cases linked to Puyallup hospital Hepatitis outbreak


Health officials say more hepatitis C cases have been linked to an outbreak at a Puyallup hospital. The News Tribune reports new tests results from the Centers For Disease Control and Prevention identified six new cases tied to the outbreak at Puyallup's Good Samaritan Hospital, bringing the total of cases up to eight.



from Biotech News
Share:

Seals can keep using San Diego children's beach, court says

Seals can keep using San Diego children's beach, court says


A California appeals court has upheld a San Diego city ordinance that closes a picturesque children's beach for nearly half the year so that seals may give birth, nurse and wean their pups. In a decision filed Thursday, the 4th District Court of Appeal reversed a lower court ruling that set aside the ordinance governing Children's Pool Beach in La Jolla, an affluent seaside community in San Diego .



from Biotech News
Share:

In the wake of Kate Spade, Anthony Bourdain deaths, how to help someone who may be at risk of suicide

In the wake of Kate Spade, Anthony Bourdain deaths, how to help someone who may be at risk of suicide


After a week in which two celebrities killed themselves, and health authorities reported an increase in suicide, mental health experts say it's time to talk more openly about a complex subject that too often is taboo. In addition to knowing the warning signs, people also should be encouraged to learn how to approach friends and loved ones they think may be at risk of hurting themselves.



from Biotech News
Share:

Somewhat Positive Press Coverage Somewhat Unlikely to Impact Fortress Biotech (FBIO) Stock Price

Somewhat Positive Press Coverage Somewhat Unlikely to Impact Fortress Biotech (FBIO) Stock Price


News headlines about Fortress Biotech have been trending somewhat positive on Thursday, according to Accern. The research firm scores the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time.



from Biotech News
Share:

CDC: U.S. Suicide Rates Have Climbed Dramatically

CDC: U.S. Suicide Rates Have Climbed Dramatically


Suicide rates have increased in nearly every state over the last two decades, and half of the states have seen suicide rates go up more than 30 percent. Suicide is a major public health issue, accounting for nearly 45,000 deaths in 2016 alone.



from Biotech News
Share:

Finanzen: Falsche Schufa-Einträge : Schufa-Eintrag löschen

Falls Sie Schwierigkeiten haben, einen Kredit oder ein Konto zu bekommen, könnte die Ursache ein fehlerhafter Eintrag bei der Schufa oder einer anderen Auskunftei sein. Mit unserem Musterbrief lässt sich das leicht beheben.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: Schufa : Schufa-Auskunft: Datenkopie nach DSGVO

Ihr Schufa-Eintrag spielt beim Kreditantrag eine entscheidende Rolle. Wir verraten Ihnen Tricks, wie Sie Ihre Daten optimieren können.

from Finanztip Feed
Supported by Video Collection
Share:

Germany's Bayer completes purchase of Monsanto

Germany's Bayer completes purchase of Monsanto


NewsOK Pro is a fast and easy way to customize your favorite news topic with some of the most popular sources from around the Web. Learn more .



from Biotech News
Share:

Finanzen: DSL Widerrufsbelehrung : Fehlerhafte Widerrufsbelehrung DSL Bank

Die DSL Bank hat in ihren Immobilienkredit-Verträgen fehlerhafte Widerrufsbelehrungen verwendet. Wollen Kunden ihre Rechte durchsetzen, brauchen sie in jedem Fall einen Anwalt.

from Finanztip Feed
Supported by Video Collection
Share:

New Ebola outbreak may open door to finding drugs that work

New Ebola outbreak may open door to finding drugs that work


As another outbreak of Ebola claims lives in central Africa, researchers are seeing within it a rare ray of hope: a chance to find a cure. For the first time, five experimental medicines are poised to undergo a real-life clinical trial against the virus at makeshift treatment centers in remote areas of the Democratic Republic of Congo, where most of the 53 new cases originated.



from Biotech News
Share:

Boston U. boosts lung cancer research with Johnson & Johnson

Boston U. boosts lung cancer research with Johnson & Johnson


School officials announced Wednesday that the company will pay for a new lung center at BU where researchers will work to prevent and cure the disease.



from Biotech News
Share:

Lava from Hawaii volcano destroys hundreds of homes overnight

Lava from Hawaii volcano destroys hundreds of homes overnight


Lava destroyed hundreds of homes in a mostly rural area of the island of Hawaii overnight, a spokeswoman said Tuesday. "We don't have an estimate yet, but safe to say that hundreds of homes were lost in Kapoho Beach Lots and Vacationland last night," said Janet Snyder, spokeswoman for Hawaii County on the Big Island.



from Biotech News
Share:

Finanzen: Rückkehr in die GKV : Rückkehr in die GKV

Privat Krankenversicherte können nur in Ausnahmefällen in eine gesetzliche Kasse zurückkehren. Je nach Alter und Einkommen gibt es dafür unterschiedliche Wege.

from Finanztip Feed
Supported by Video Collection
Share:

Opinion: UC helps drive California biotech; don't disinvest

Opinion: UC helps drive California biotech; don't disinvest


University of California research innovations have helped Bay Area biotech companies usher in breakthroughs in cancer immunotherapy, disease prevention, vaccines, precision medicine and prosthetics while generating high-paying jobs and tax revenues for the Golden State. And so it's little wonder that Bay Area biotech leaders - especially those of us who graduated from UC campuses - are closely watching how Gov. Jerry Brown funds California's top-ranking research university system in the 2018-19 state budget.



from Biotech News
Share:

Finanzen: Kredit ohne Schufa : Kredit ohne Schufa

Es ist möglich, ohne eine Schufa-Prüfung zum Kredit zu kommen. Unseriöse Vermittler versuchen, die Not der Kunden auszunutzen.

from Finanztip Feed
Supported by Video Collection
Share:

CDC: 5 dead, close to 200 sick in worst E. coli outbreak since 2006 Source: Cox Media Group

CDC: 5 dead, close to 200 sick in worst E. coli outbreak since 2006 Source: Cox Media Group


Four additional people died and hundreds fell ill after an E. coli outbreak linked to romaine lettuce , the Atlanta-based Centers for Disease Control and Prevention announced Friday. Victims of the illness died in California, Pennsylvania, Arkansas, Minnesota and New York, the CDC reported.



from Biotech News
Share:

Finanzen: Kredite von Privat : Privatkredit

Geld von Verwandten oder guten Bekannten zu leihen, kann billiger sein als bei der Bank. Es gibt aber auch Online-Plattformen, die Privatkredite vermitteln.

from Finanztip Feed
Supported by Video Collection
Share:

AmerisourceBergen (ABC) Stake Decreased by California Public Employees Retirement System

AmerisourceBergen (ABC) Stake Decreased by California Public Employees Retirement System


California Public Employees Retirement System trimmed its stake in shares of AmerisourceBergen by 3.2% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 434,560 shares of the company's stock after selling 14,145 shares during the quarter.



from Biotech News
Share:

Bayer to close Monsanto takeover, to retire target's name

Bayer to close Monsanto takeover, to retire target's name


Germany's Bayer will wrap up the US$62.5 billion takeover of Monsanto on Thursday this week and also retire the name of the U.S. seeds maker, it said on Monday. FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal, Germany February 24, 2014.



from Biotech News
Share:

Mixed results for Bristol/Nektar combination in cancer trial

Mixed results for Bristol/Nektar combination in cancer trial


Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co's cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led at least one Wall Street analyst to reassess expectations. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018.



from Biotech News
Share:

Sommerhitze: Fast 30 Millionen Arzneimittel müssen gekühlt werden

Sommerhitze: Fast 30 Millionen Arzneimittel müssen gekühlt werden


image description
In Deutschland werden jedes Jahr fast 30 Millionen besonders temperaturempfindliche Arzneimittel abgegeben. Gerade an heißen Sommertagen müssen sie gekühlt werden, damit sie wirksam bleiben. Die Zahl entspricht knapp fünf Prozent der jährlich mehr als 660 Millionen ärztlich verordneten Medikamente, ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Novartis schliesst Verkauf von Consumer-Healthcare-Joint-Venture ab

Novartis schliesst Verkauf von Consumer-Healthcare-Joint-Venture ab


(dpa-AFX) Der Pharmakonzern Novartis hat den im vergangenen März angekündigten Verkauf des Anteils am Joint-Venture mit GlaxoSmithKline (GSK) abgeschlossen. Der Verkauf des Anteils am Gemeinschaftsunternehmen im Bereich Consumer Healthcare für 13 Milliarden US-Dollar sei vollzogen worden, teilt das ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Eli Lilly helping hurricane Maria victims

Eli Lilly helping hurricane Maria victims


The first team of Hoosier helpers from Eli Lilly and Company returned home from delivering critical care to people living in hurricane-stricken Puerto Rico on Saturday. Dawn Justus is a nurse and part of the team of Lilly workers that fanned out across Puerto Rico to help those still recovering - especially those suffering from diabetes.



from Biotech News
Share:

Natixis Advisors L.P. Has $52.34 Million Stake in Amgen

Natixis Advisors L.P. Has $52.34 Million Stake in Amgen


Natixis Advisors L.P. increased its stake in shares of Amgen by 5.2% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 307,012 shares of the medical research company's stock after purchasing an additional 15,153 shares during the quarter.



from Biotech News
Share:

Roche drugs show limited benefit in lung, breast cancer trials

Roche drugs show limited benefit in lung, breast cancer trials


In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung cancer and breast cancer, according to data from separate clinical trials presented on Saturday. Adding Roche's high-profile immunotherapy Tecentriq to other standard cancer drugs extended by only about three weeks the median time patients with advanced squamous cell lung cancer lived before their disease progressed in one late stage study.



from Biotech News
Share:

Cellect Biotech/S (Apop) Rating Reiterated by HC Wainwright

Cellect Biotech/S (Apop) Rating Reiterated by HC Wainwright


"We continue to expect that this cushion should be sufficient to fund operations through 2019. The January 2018 financing included unregistered warrants with an exercise price of $12.00 per ADS, which could if exercised in full accrue an additional $3.2M to the company.



from Biotech News
Share:

How Allergan went from a tiny but beloved Southern California...

How Allergan went from a tiny but beloved Southern California...


How Allergan went from a tiny but beloved Southern California eye care company to a dealmaking machine to falling out of grace with investors and some have expressed interest in seeing the pharma company explore splitting up. On Wednesday, Allergan announced it plans to sell its women's health and infectious disease businesses .



from Biotech News
Share:

Bluebird myeloma treatment delays cancer progression: Trial

Bluebird myeloma treatment delays cancer progression: Trial


A cancer patient receives radiation treatment at a government cancer hospital in Agartala, the capital of northeastern state of Tripura on Feb 3, 2017, on the eve of World Cancer Day. CHICAGO: Patients with advanced multiple myeloma treated with bluebird bio's experimental immunotherapy lived for a median of nearly a year before their cancer worsened, according to data from a small study presented on Friday.



from Biotech News
Share:

Texas-based meatpacker recalls 9 tons of smoked sausage

Texas-based meatpacker recalls 9 tons of smoked sausage


It's the company's second recall in a month. Eddy Packing Co. - based in Yoakum, Texas - recalled 9 tons of smoked sausage for possible contamination.



from Biotech News
Share:

Texas-based meatpacker recalls 9 tons of smoked sausage

Texas-based meatpacker recalls 9 tons of smoked sausage


It's the company's second recall in a month. Eddy Packing Co. - based in Yoakum, Texas - recalled 9 tons of smoked sausage for possible contamination.



from Biotech News
Share:

Will Big Data Lead to Big Biotech Returns?

Will Big Data Lead to Big Biotech Returns?


Big Data could improve results in the biopharmaceutical industry-if companies can improve their use and avoid pitfalls, writes Jefferies' Michael Yee in a report issued today. The proper implementation of new data and analytics tools could "accelerate the probability of success" in the drug industry and boost process efficiencies, driving billions in cost savings, according to Yee.



from Biotech News
Share:

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings


Mr. Elkins will join... )--Analog Devices, Inc. today announced that Senior Vice President, Finance and Chief Financial Officer Prashanth Mahendra-Rajah will speak at the Bank o... )--The "Wearable Health Tracking Devices Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The wearable health tracking devices... )--W.



from Biotech News
Share:

Aeterna Zentaris Appoints Olaf Althaus as General Manager and...

Aeterna Zentaris Appoints Olaf Althaus as General Manager and...


Aeterna Zentaris Inc. announced that Olaf Althaus has been appointed to the position of General Manager and Managing Director of Aeterna Zentaris GmbH in Frankfurt, Germany, effective June 1, 2018. Mr. Althaus has over 17 years of executive experience in the pharmaceutical industry and 10 years in investment banking.



from Biotech News
Share:

Bayer stellt Organisation für Pharmaforschung und -Entwicklung auf den Prüfstand

Bayer stellt Organisation für Pharmaforschung und -Entwicklung auf den Prüfstand


(dpa-AFX) Bayer überprüft weltweit die Organisation seiner Forschung und Entwicklung im Pharmageschäft. Ein Sprecher des Konzerns bestätigte am Donnerstag auf Anfrage in diesem Punkt einen entsprechenden Vorabbericht der "Wirtschaftswoche". Die Prüfung diene dazu, "Wachstum durch Innovation" sicherz...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Epilepsie: Neue Forschung, neue Hoffnung

Epilepsie: Neue Forschung, neue Hoffnung


image description
Die Ursache für eine Erkrankung zu kennen, ist der Schlüssel für die Forschung und Entwicklung eines wirksamen Medikaments. Seit dem 19. Jahrhundert weiß die Medizin: In ihrer normalen Funktion gestörte Nervenzellen im Gehirn sind für epileptische Anfälle verantwortlich. So wurde 1859 mit Brom einer...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.
Share:

Finanzen: Versicherungsberater und Versicherungsmakler : Versicherungsberater und Versicherungsmakler

Versicherungsberater stehen für unabhängige Beratung. Außerdem gibt es Versicherungsmakler und -vertreter. Lesen Sie hier, wer am besten zu Ihnen passt.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: PV-Steuer : Photovoltaik Steuer auf Solarstrom

Der günstigste Strom, ist der, den Sie selbst mit einer Photovoltaik-Anlage erzeugen. Verkaufen Sie Teile davon, müssen Sie Steuern zahlen. Finanztip erklärt, was zu beachten ist.

from Finanztip Feed
Supported by Video Collection
Share:

Finanzen: LTE : LTE

LTE macht das Surfen unterwegs und zu Hause schneller. Doch nicht jeder kann den schnellen Datenfunk sofort nutzen.

from Finanztip Feed
Supported by Video Collection
Share:

Chinaa s slow approvals of biotech crops cost U.S. $7 billion, says industry group

Chinaa s slow approvals of biotech crops cost U.S. $7 billion, says industry group


Delays in Chinese approvals of imported genetically modified crops have cut U.S. gross domestic product by about $7 billion over the past five years by reducing sales of crops and other goods, an industry group that represents global seed companies said on Wednesday. The report by CropLife International indicates what is at stake for the administration of President Donald Trump as it seeks better access for U.S. GMO crops into China as part of a trade deal under discussion.



from Biotech News
Share:

Pharmacy News Digest

Архив блога